发明名称 Antigenic modulation of cells
摘要 The present invention is directed to a non-immunogenic cellular composition comprising: a cell having a cell surface and antigenic determinants on the cell surface; an optional linker molecule covalently attached to the cell surface; and a non-immunogenic compound (e.g. polyethylene glycol or a derivative thereof) covalently attached to the linker molecule or directly to the cell. In one embodiment, the linker molecule is covalently attached directly to the antigenic determinant on the cell surface. In an alternative embodiment, the linker molecule may be covalently attached to a non-antigenic site on the cell surface. Various uses of the resulting non-immunogenic cell are also provided, including a method of decreasing phagocytosis of a cell, a method of decreasing an adverse reaction to a transfusion, a method of decreasing rejection of a transplanted cell, tissue or organ, and a method of decreasing antibody-induced aggregation of cells.
申请公布号 AU1555297(A) 申请公布日期 1997.08.22
申请号 AU19970015552 申请日期 1997.02.03
申请人 BIOMEDICAL FRONTIERS, INC. 发明人 JOHN EATON;SEONG-TAE JEONG;MARK D. SCOTT
分类号 A61K31/00;A61K35/12;A61K35/18;A61K35/36;A61K35/39;A61K35/407;A61K39/00;A61P37/00;A61P37/06;C12N5/00;C12N5/078 主分类号 A61K31/00
代理机构 代理人
主权项
地址